Impact of plaque composition on long-term clinical outcomes in patients with coronary artery occlusive disease

It is unclear which plaque component is related with long-term clinical outcomes in patients with coronary artery occlusive disease (CAOD). We assessed the relationship between plaque compositions and long-term clinical outcomes in those patients. The study subjects consisted of 339 consecutive pati...

Full description

Saved in:
Bibliographic Details
Published inKorean circulation journal Vol. 43; no. 6; pp. 377 - 383
Main Authors Kim, Ki Hong, Kim, Wan Ho, Park, Hyun Woong, Song, In Girl, Yang, Dong Ju, Seo, Young Hoon, Yuk, Hyung Bin, Park, Yo Han, Kwon, Taek Geun, Rihal, Charanjit S, Lerman, Amir, Lee, Moo-Sik, Bae, Jang-Ho
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Cardiology 01.06.2013
대한심장학회
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:It is unclear which plaque component is related with long-term clinical outcomes in patients with coronary artery occlusive disease (CAOD). We assessed the relationship between plaque compositions and long-term clinical outcomes in those patients. The study subjects consisted of 339 consecutive patients (mean 61.7±12.2 years old, 239 males) who underwent coronary angiogram and a virtual histology-intravascular ultrasound examination. Major adverse cardiac and cerebrovascular events (MACCE), including all-cause death, non-fatal myocardial infarction, cerebrovascular events, and target vessel revascularization were evaluated during a mean 28-month follow-up period. Patients with high fibrofatty volume (FFV, >8.90 mm(3), n=169) had a higher incidence of MACCE (25.4% vs. 14.7%, p=0.015), male sex (75.7% vs. 65.3%, p=0.043), acute coronary syndrome (53.3% vs. 35.9%, p=0.002), multivessel disease (62.7% vs. 41.8%, p<0.001) and post-stent slow flow (10.7% vs. 2.4%, p=0.002) than those with low FFV (FFV≤8.90 mm(3), n=170). Other plaque composition factors such as fibrous area/volume, dense calcified area/volume, and necrotic core area/volume did not show any impact on MACCE. Cardiogenic shock {hazard ratio (HR)=8.44; 95% confidence interval (CI)=3.00-23.79; p<0.001} and FFV (HR=1.85; 95% CI=1.12-3.07; p=0.016) were the independent predictors of MACCE by Cox regression analysis. Thin-cap fibroatheroma, necrotic core area, and necrotic core volume were not associated with MACCE. FFV of a culprit lesion was associated with unfavorable long-term clinical outcomes in patients with CAOD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000708.2013.43.6.004
ISSN:1738-5520
1738-5555
DOI:10.4070/kcj.2013.43.6.377